Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020136627 - ISOLATED OR SYNTHETIC CANNABINOID COMPOSITIONS WITH SELECTED TERPENE BLEND AND METHODS OF USE THEREOF

Publication Number WO/2020/136627
Publication Date 02.07.2020
International Application No. PCT/IB2019/061421
International Filing Date 28.12.2019
IPC
A61K 31/352 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/01 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
01Hydrocarbons
A61K 36/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 47/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
CPC
A61K 31/01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
01Hydrocarbons
A61K 31/015
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
01Hydrocarbons
015carbocyclic
A61K 31/045
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A61K 31/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
Applicants
  • BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. [IL]/[IL]
Inventors
  • RAZ, Noa
  • EYAL, Aharon
Agents
  • DIAMANT, Barbara
Priority Data
62/786,35029.12.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ISOLATED OR SYNTHETIC CANNABINOID COMPOSITIONS WITH SELECTED TERPENE BLEND AND METHODS OF USE THEREOF
(FR) COMPOSITIONS DE CANNABINOÏDES ISOLÉS OU SYNTHÉTIQUES ET D'UN MÉLANGE DE TERPÈNES SÉLECTIONNÉS ET LEURS PROCÉDÉS D'UTILISATION
Abstract
(EN)
A therapeutic product comprising (i) at least one selected cannabinoid in a specific amount, wherein at least a fraction of said selected cannabinoid is derived from processing hemp, chemical synthesis, biological synthesis, isolation from plant source and combination thereof, (ii) optionally, at least one other cannabinoid, (iii) a primary terpene in a specific amount, and (iv) optionally at least three secondary terpenes; forming a terpene-enriched cannabinoid product with an enhanced therapeutic effect compared with that of a product comprising the same cannabinoids amount and no terpene.
(FR)
L'invention concerne un produit thérapeutique qui comporte (i) au moins un cannabinoïde sélectionné en une quantité précise, au moins une fraction dudit cannabinoïde sélectionné étant issue du traitement du chanvre, d'une synthèse chimique, d'une synthèse biologique, d'un isolement de la source végétale et d'une combinaison de ces procédés, (ii) éventuellement, au moins un autre cannabinoïde, (iii) un terpène primaire en une quantité précise, et (iv) éventuellement, au moins trois terpènes secondaires ; la formation d'un produit à base de cannabinoïdes enrichi en terpène(s) offrant un effet thérapeutique amélioré par rapport à celui d'un produit comportant la même quantité de cannabinoïdes mais sans terpène.
Latest bibliographic data on file with the International Bureau